CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −200 | $120.16 | $24K | 29,521 |
| 2023-12-08 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +100 | $81.05 | $8K | 29,621 |
| 2023-12-08 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −100 | $120.00 | $12K | 29,521 |
| 2023-12-08 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −200 | $81.05 | $16K | 53,465 |
| 2023-12-08 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −100 | $81.05 | $8K | 53,365 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +38,722 | $77.81 | $3.0M | 68,243 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −38,722 | $120.37 | $4.7M | 29,521 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +12,742 | $77.81 | $991K | 42,263 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −12,742 | $120.37 | $1.5M | 29,521 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +14,140 | $79.02 | $1.1M | 43,661 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −14,140 | $120.37 | $1.7M | 29,521 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +11,775 | $81.05 | $954K | 41,296 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −11,775 | $120.37 | $1.4M | 29,521 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −38,722 | $77.81 | $3.0M | 12,742 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −12,742 | $77.81 | $991K | 0 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −14,140 | $79.02 | $1.1M | 60,005 |
| 2023-12-07 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −11,775 | $81.05 | $954K | 53,665 |
| 2023-12-06 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +8,396 | $77.81 | $653K | 37,917 |
| 2023-12-06 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −8,396 | $120.03 | $1.0M | 29,521 |
| 2023-12-06 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −8,396 | $77.81 | $653K | 51,464 |
Page 42 of 49 · 963 trades